亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors

医学 四分位间距 脑膜瘤 放射治疗 队列 比例危险模型 内科学 核医学 肿瘤科 外科
作者
Isacco Desideri,I. Morelli,Marco Banini,Daniela Greto,Luca Visani,Filippo Nozzoli,Saverio Caini,Alessandro Della Puppa,Lorenzo Livi,Zeno Perini,Emanuele Zivelonghi,Giorgia Bulgarelli,Valentina Pinzi,Pierina Navarria,Elena Clerici,Marta Scorsetti,A.M. Ascolese,Mattia Falchetto Osti,Paola Anselmo,Dante Amelio,Giuseppe Minniti,D. Scartoni
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:195: 110271-110271 被引量:2
标识
DOI:10.1016/j.radonc.2024.110271
摘要

Purpose Re-irradiation (re-RT) for recurrent intracranial meningiomas is hindered by the limited radiation tolerance of surrounding tissue and the risk of side effects. This study aimed at assessing outcomes, toxicities and prognostic factors in a cohort of patients with recurrent meningiomas re-treated with different RT modalities. Materials and methods A multi-institutional database from 8 Italian centers including intracranial recurrent meningioma (RM) patients who underwent re-RT with different modalities (SRS, SRT, PT, EBRT) was collected. Biologically Equivalent Dose in 2 Gy-fractions (EQD2) and Biological Effective Dose (BED) for normal tissue and tumor were estimated for each RT course (α/β = 2 for brain tissue and α/β = 4 for meningioma). Primary outcome was second progression-free survival (s-PFS). Secondary outcomes were overall survival (OS) and treatment-related toxicity. Kaplan–Meier curves and Cox regression models were used for analysis. Results Between 2003 and 2021 181 patients (pts) were included. Median age at re-irradiation was 62 (range 20–89) and median Karnofsky Performance Status (KPS) was 90 (range 60–100). 78 pts were identified with WHO grade 1 disease, 65 pts had grade 2 disease and 10 pts had grade 3 disease. 28 pts who had no histologic sampling were grouped with grade 1 patients for further analysis. Seventy-five (41.4 %) patients received SRS, 63 (34.8 %) patients SRT, 31 (17.1 %) PT and 12 (6.7 %) EBRT. With a median follow-up of 4.6 years (interquartile range 1.7–6.8), 3-year s-PFS was 51.6 % and 3-year OS 72.5 %. At univariate analysis, SRT (HR 0.32, 95 % CI 0.19–0.55, p < 0.001), longer interval between the two courses of irradiation (HR 0.37, 95 % CI 0.21–0.67, p = 0.001), and higher tumor BED (HR 0.45 95 % CI 0.27–0.76, p = 0.003) were associated with longer s-PFS; in contrast, Ki67 > 5 % (HR 2.81, 95 % CI 1.48–5.34, p = 0.002) and WHO grade > 2 (HR 3.08, 95 % CI 1.80–5.28, p < 0.001) were negatively correlated with s-PFS. At multivariate analysis, SRT, time to re-RT and tumor BED maintained their statistically significant prognostic impact on s-PFS (HR 0.36, 95 % CI 0.21–0.64, p < 0.001; HR 0.38, 95 % CI 0.20–0.72, p = 0.003 and HR 0.31 95 % CI 0.13–0.76, p = 0.01, respectively). Acute and late adverse events (AEs) were reported in 38 (20.9 %) and 29 (16 %) patients. Larger tumor GTV (≥10 cc) was significantly associated with acute and late toxicity (p < 0.001 and p = 0.009, respectively). Conclusions In patients with recurrent meningiomas, reirradiation is a feasible treatment option associated with acceptable toxicity profile. Prognostic factors in the decision-making process have been identified and should be incorporated in daily practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
6秒前
仁爱的鞋子完成签到,获得积分10
21秒前
安详老鼠完成签到,获得积分10
24秒前
28秒前
29秒前
Shu完成签到,获得积分10
30秒前
刻苦的煎蛋完成签到,获得积分10
37秒前
庾傀斗发布了新的文献求助10
38秒前
ssgg完成签到,获得积分10
47秒前
辛勤诗兰完成签到,获得积分10
49秒前
52秒前
不爱写论文完成签到,获得积分10
53秒前
HaoZhang发布了新的文献求助10
54秒前
59秒前
Lynee完成签到,获得积分10
59秒前
清脆妙梦完成签到,获得积分10
1分钟前
sugar发布了新的文献求助10
1分钟前
小辣椒完成签到,获得积分10
1分钟前
HaoZhang完成签到,获得积分20
1分钟前
尊敬康乃馨完成签到,获得积分10
1分钟前
初景发布了新的文献求助10
1分钟前
zhaodan完成签到,获得积分10
1分钟前
思源的应助被sugar采纳,获得30
1分钟前
贪玩芝完成签到 ,获得积分10
1分钟前
guyuzheng完成签到,获得积分10
1分钟前
爱听歌谷蓝完成签到,获得积分10
1分钟前
魔幻的芳完成签到,获得积分10
1分钟前
123啊完成签到 ,获得积分10
1分钟前
1分钟前
悲凉的忆南完成签到,获得积分10
1分钟前
cmq123发布了新的文献求助10
1分钟前
陈旧完成签到,获得积分10
1分钟前
谷野完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
欣欣子完成签到,获得积分10
1分钟前
酷波er的应助被cmq123采纳,获得10
1分钟前
yxl完成签到,获得积分10
1分钟前
可耐的盈完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195111
求助须知:如何正确求助?哪些是违规求助? 9580886
关于积分的说明 21872823
捐赠科研通 7794997
什么是DOI,文献DOI怎么找? 3437934
关于科研通互助平台的介绍 2561228
邀请新用户注册赠送积分活动 2484609